88 related articles for article (PubMed ID: 2439425)
1. Antithyroid drugs--a rational treatment for Graves' disease?
Leclère J
Horm Res; 1987; 26(1-4):125-30. PubMed ID: 2439425
[TBL] [Abstract][Full Text] [Related]
2. Graves' disease in childhood: advances in management with antithyroid drug therapy.
Kaguelidou F; Carel JC; Léger J
Horm Res; 2009; 71(6):310-7. PubMed ID: 19506387
[TBL] [Abstract][Full Text] [Related]
3. [Radioiodine therapy of Graves' disease--a dosimetric comparison of various therapy regimens of antithyroid agents].
Urbannek V; Voth E; Moka D; Schicha H
Nuklearmedizin; 2001 Aug; 40(4):111-5. PubMed ID: 11556200
[TBL] [Abstract][Full Text] [Related]
4. Influence of short-term interruption of antithyroid drugs on the outcome of radioiodine therapy of Graves' disease: results of a prospective study.
Eschmann SM; Thelen MH; Dittmann H; Bares R
Exp Clin Endocrinol Diabetes; 2006 May; 114(5):222-6. PubMed ID: 16804795
[TBL] [Abstract][Full Text] [Related]
5. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Graves' hyperthyroidism: evidence-based and emerging modalities.
Hegedüs L
Endocrinol Metab Clin North Am; 2009 Jun; 38(2):355-71, ix. PubMed ID: 19328416
[TBL] [Abstract][Full Text] [Related]
7. Efficiency analysis of using tailored individual doses of radioiodine and fine tuning using a low-dose antithyroid drug in the treatment of Graves' disease.
Liu CJ; Dong YY; Wang YW; Wang KH; Zeng QY
Nucl Med Commun; 2011 Mar; 32(3):227-32. PubMed ID: 21191313
[TBL] [Abstract][Full Text] [Related]
8. [The surgical treatment of Graves' disease].
de Ruijter SH; van Dalen T; Muller AF
Ned Tijdschr Geneeskd; 2006 Jun; 150(24):1321-5. PubMed ID: 16808361
[TBL] [Abstract][Full Text] [Related]
9. [Hyperthyroidism in Graves' disease--antithyroid drug treatment].
Schumm-Draeger PM
Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():41-5. PubMed ID: 10355049
[TBL] [Abstract][Full Text] [Related]
10. Optimizing remission rates using antithyroid drugs for Graves' disease.
Hegedüs L
Clin Endocrinol (Oxf); 2010 Jun; 72(6):729-30. PubMed ID: 20050856
[No Abstract] [Full Text] [Related]
11. Reassessment of antithyroid drug therapy of Graves' disease.
Feldt-Rasmussen U; Glinoer D; Orgiazzi J
Annu Rev Med; 1993; 44():323-34. PubMed ID: 7682804
[TBL] [Abstract][Full Text] [Related]
12. Different strategies to overcome the effect of carbimazole on high- and low-dose radioiodine therapy: results from continuous dose-effect models.
Walter MA; Schindler C; Christ-Crain M; Müller-Brand J; Müller B
Eur J Clin Invest; 2009 Jan; 39(1):51-7. PubMed ID: 19087129
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of Basedow disease with synthetic antithyroid drugs. Evaluation of the dose on the efficacy of the long term treatment].
Leclere J
Ann Endocrinol (Paris); 1994; 55(1):11-4. PubMed ID: 7528485
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors for the Relapse of Graves' Disease Treated With Antithyroid Drugs: A Systematic Review and Meta-analysis.
Shi H; Sheng R; Hu Y; Liu X; Jiang L; Wang Z; Cui D
Clin Ther; 2020 Apr; 42(4):662-675.e4. PubMed ID: 32139177
[TBL] [Abstract][Full Text] [Related]
15. Antithyroid drug therapy: predictive parameters.
Feldt-Rasmussen U
Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():53-5. PubMed ID: 10355051
[TBL] [Abstract][Full Text] [Related]
16. [Effect of thyroxine upon prevention of recurrence of Graves' disease treated with antithyroid drugs].
Wu G; Jie Y; Situ Y
Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(5):274-5. PubMed ID: 11798886
[TBL] [Abstract][Full Text] [Related]
17. Comparison of long-term antithyroid drugs versus radioactive iodine or surgery for Graves' disease: A review of the literature.
El Kawkgi OM; Ross DS; Stan MN
Clin Endocrinol (Oxf); 2021 Jul; 95(1):3-12. PubMed ID: 33283314
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Graves' hyperthyroidism--prognostic factors for outcome.
Alfadda A; Malabu UH; El-Desouki MI; Al-Rubeaan KA; Al-Ruhaily AD; Fouda MA; Al-Maatouq MA; Sulimani RA
Saudi Med J; 2007 Feb; 28(2):225-30. PubMed ID: 17268701
[TBL] [Abstract][Full Text] [Related]
19. [Treatment with iodine radioisotopes and thyroid-associated ophthalmopathy in Graves' disease].
Rasmussen AK; Feldt-Rasmussen UF
Ugeskr Laeger; 1999 Oct; 161(43):5933-4. PubMed ID: 10778332
[No Abstract] [Full Text] [Related]
20. Optimal iodine supplementation during antithyroid drug therapy for Graves' disease is associated with lower recurrence rates than iodine restriction.
Huang H; Shi Y; Liang B; Cai H; Cai Q; Lin R
Clin Endocrinol (Oxf); 2018 Mar; 88(3):473-478. PubMed ID: 29288501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
